Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma
NCT ID: NCT02561533
Last Updated: 2017-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2014-12-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pyrosequencing of the BRAFV600E Mutation
NCT00551486
Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma
NCT04664413
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
NCT06133374
Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY
NCT05766098
A Gene Hunting Study for Familial Papillary Thyroid Cancer
NCT02776969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
FNABs are performed immediately before the thyroid operation, and BRAF-V600E detection using VE1 is performed on clots. The VE1 stain is compared to the mutation status of the removed cancer or control tissue using the Cobas test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BRAF immunohistochemistry (IHC)
BRAF detection on fine needle aspiration biopsy (FNAB)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BRAF detection on fine needle aspiration biopsy (FNAB)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing thyroid surgery (histology of index nodule)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristine Zøylner Rubeck
MD PhD-student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus C, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TIHCDBMTC1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.